1. General Information

Nahda Medical Journal (NMJ) is a peer-reviewed scientific journal that publishes high-quality scientific manuscripts in the fields of medicine and health sciences.

Submitted manuscripts must be original works, not previously published, and not under review in another journal.

Types of manuscripts accepted include: Original Research Articles, Review Articles, Systematic Reviews, Meta-Analyses, Case Reports, Short Communications.

2. Focus and Scope

Focus and Scope Nahda Medical Journal accepts manuscripts within the following scope:

1. Clinical Medicine — diagnostic studies, management, and clinical outcomes in various fields of medical specialization (internal medicine, surgery, pediatrics, obstetrics-gynecology, and other clinical disciplines).
2. Medical Education — curriculum, teaching methods, educational evaluation, faculty workload and development, clinical competencies, as well as competency-based learning innovations in medical education institutions, including the context of newly established medical schools.
3. Public Health and Epidemiology — determinants of population health, communicable and non-communicable diseases, health promotion, and health issues specific to island and rural areas.
4. Family Medicine and Primary Care — primary health care services, continuity of care, and community-based health service models.
5. Medical Ethics, Health Law, and Policy — aspects of medical practice law, clinical ethics, healthcare governance, and national and regional health policies.
6. Medicine and Islamic Values (Islamic Bioethics/Medicine) — integration of Islamic values in medical practice and education, Islamic bioethics, and health studies from the perspective of pesantren.
7. Maternal and Child Health, Nutrition, and Reproductive Health — in accordance with the priority health needs of the region.
8. Clinical Pharmacology and Basic Biomedical Sciences — translational research relevant to clinical practice.

3. Submission Documents

1. Manuscript and title page in 1 file.
2. Cover letter.
3. Research ethics approval and informed consent file (The Editor-in-Chief may request a copy of the ethics approval and informed consent for all research involving human subjects).
4. Image and table files listed in the manuscript should also be uploaded separately in OJS.
5. Disclosure of interest form file according to ICJME form https://www.icmje.org/disclosure-of-interest/

4. Persiapan manuscript

1. Prepare your manuscript using a word processing program and save it in .doc format using Microsoft Word.
2. The manuscript must consist of a maximum of 4000 words, with a maximum of 5 tables and figures (Total), and contain at least 25 references. The manuscript original and review article must not exceed 250 words and include the following sections: Abstract, Introduction, Materials and Methods, Results, Discussion, Conclusion, Strengths and Limitation, Conflict of Interest, Acknowledgments, Ethical Approval, Declaration of Usiang AI, and Reference. For case report must not exceed 200 words and include the following sections: Abstract, Introduction, case report Discussion, Conclusion, Strengths and Limitation, Conflict of Interest, Acknowledgments, Ethical Approval, Declaration of Usiang AI, and Reference. The text must use a font size of Times New Roman 11pt Bold, Space 1, Center for manuscript sturcture, and Times New Roman 10pt Bold, Space 1, Justify for manuscript content.
3. Authors are advised to limit the use of abbreviations as much as possible, especially if the abbreviations are not standard, and only use them if the abbreviation is clearer than the full term (e.g., PCR, DNA). Avoid using abbreviations in the title of the manuscript. When first mentioned, all abbreviations must be written in full, followed by their abbreviation in parentheses, unless the abbreviation is a standard unit of measurement.
4. The trade name of the drug should not appear in the title, but it can be used along with the generic name when first mentioned in the abstract. Thereafter, only the generic name should be used. The genus and species names must be italicized and written in full upon first use, after which they can be abbreviated to one letter (e.g., E. Coli).
5. Table should be numbered consecutively according to the order in which they have been cited in the text. Each table must be numbered using Arabic numerals and titled above the table, and accompanied by a brief description that clearly explains the purpose or content of the table and placed below the table. Do not use horizontal or vertical lines inside the table. If the table uses data from other published sources, obtain permission to use the data and cite the source completely.
6. Figure should be numbered consecutively according to the order in which they have been cited in the text. Each figure must be numbered using Arabic numerals and titled below the figure, and accompanied by a brief description that clearly explains the purpose or content of the figure. Figure must be created professionally or well-photographed, and submitted in jpg, .jpeg, .tif. Format with a minimum resolution of 300 dpi. In photomicrographs, symbols, arrows, or letters used must have clear contrast. If symbols, arrows, numbers, or letters are used to identify parts in the illustration, each element must be clearly identified and explained in the figure legend. Figure that display potentially identifiable individuals must be accompanied by written consent for the use of the photo.
7. For the measurement and concentration of drugs, use local units and S.I. units (International System of Units/Sistem Internasional). Measurement units must be written in abbreviated form (e.g., mm, kcal, etc.). Temperature must be expressed in degrees Celsius (°C). Blood pressure must be stated in millimeters of mercury (mmHg).
8. The explanation for each chapter manuscript structure and content (Abstract, Introduction, Materials and Methods, Results, Discussion, Conclusion, Strengths and Limitation, Conflict of Interest, Acknowledgments, Ethical Approval, Declaration of Usiang AI, and Reference) can be found in the provided template.

j. Turnaround Times

k. Review Process

Review process NMJ is a double blind journal. Manuscripts are reviewed anonymously by at least two independent reviewers selected by the Editors.

The internal procedures of NMJ ensure that this standard is also maintained for all articles authored by members of the Editorial Team.

l. Rejection of Manuscript

Manuscripts that discuss topics that have been extensively researched in the literature but do not provide answers to questions arising from previous studies, or manuscripts that have inadequate statistical power, are likely to be rejected without undergoing the peer review process.

Articles that have the potential to influence the selection, implementation, or interpretation of clinical examinations will be prioritized over articles that do not have such an impact.

Research on animals or cell cultures must provide a clear justification for its suitability for publication.

Reporting negative results must be supported by prior evidence indicating that positive results should have been expected.

The manuscript will also be returned to the author if it does not meet the Author Guidelines, for example, if the word count exceeds the limit set for a specific type of article.